1)Tempfer CB, Tischoff I, Dogan A, et al : Neuroendocrine carcinoma of the cervix : a systematic review of the literature. BMC Cancer 18 : 530, 2018
2)日本産婦人科学会・日本病理学会 : 子宮頸癌取り扱い規約第4版.金原出版,pp46-48,2017
3)Salvo G, Gonzalez Martin A, Gonzales NR, et al : Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer 29 : 986-995, 2019
4)Gadducci A, Carinelli S, Aletti G : Neuroendrocrine tumors of the uterine cervix : A therapeutic challenge for gynecologic oncologists. Gynecol Oncol 144 : 637-646, 2017
5)Komiyama S, Nishio E, Torii Y, et al : A case of primary uterine cervical neuroendocrine tumor with meningeal carcinomatosis confirmed by diagnostic imaging and autopsy. Int J Clin Oncol 16 : 581-586, 2011
6)Chan JK, Loizzi V, Burger RA, et al : Prognostic factors in neuroendocrine small cell cervical carcinoma : a multivariate analysis. Cancer 97 : 568-574, 2003
7)Embry JR, Kelly MG, Post MD, et al : Large cell neuroendocrine carcinoma of the cervix : prognostic factors and survival advantage with platinum chemotherapy. Gynecol Oncol 120 : 444-448, 2011
8)Hoskins PJ, Swenerton KD, Pike JA, et al : Small-cell carcinoma of the cervix : fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21 : 3495-3501, 2003
9)Wang KL, Chang TC, Jung SM, et al : Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix : a Taiwanese Gynecologic Oncology Group study. Eur J Cancer 48 : 1484-1494, 2012
10)Tangjitgamol S, Manusirivithaya S, Choomchuay N, et al : Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix. J Obstet Gynaecol Res 33 : 218-224, 2007
11)Tewari KS, Sill MW, HJ 3rd, et al : Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370 : 734-743, 2014
12)Tangjitgamol S, Ramirez PT, Sun CC, et al : Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix : a clinicopathologic and prognostic study. Int J Gynecol Cancer 15 : 646-656, 2015